Q1 2024 EPS Estimates for P3 Health Partners Inc. (NASDAQ:PIII) Cut by William Blair

P3 Health Partners Inc. (NASDAQ:PIIIFree Report) – William Blair reduced their Q1 2024 earnings per share (EPS) estimates for P3 Health Partners in a research note issued on Monday, April 1st. William Blair analyst R. Daniels now forecasts that the company will post earnings of ($0.19) per share for the quarter, down from their prior estimate of ($0.15). William Blair currently has a “Outperform” rating on the stock. The consensus estimate for P3 Health Partners’ current full-year earnings is ($0.54) per share. William Blair also issued estimates for P3 Health Partners’ Q2 2024 earnings at ($0.17) EPS, Q3 2024 earnings at ($0.12) EPS, Q4 2024 earnings at ($0.09) EPS, FY2024 earnings at ($0.56) EPS and FY2025 earnings at ($0.49) EPS.

Other equities research analysts have also recently issued reports about the stock. Lake Street Capital reduced their price target on shares of P3 Health Partners from $9.00 to $4.50 and set a “buy” rating for the company in a research report on Thursday, March 14th. BTIG Research lowered shares of P3 Health Partners from a “buy” rating to a “neutral” rating in a research note on Monday.

Get Our Latest Research Report on PIII

P3 Health Partners Stock Down 0.2 %

P3 Health Partners stock traded down $0.00 during trading on Wednesday, reaching $0.79. The stock had a trading volume of 207,071 shares, compared to its average volume of 380,703. P3 Health Partners has a 52-week low of $0.66 and a 52-week high of $5.56. The business has a 50 day moving average price of $1.05 and a 200 day moving average price of $1.26. The company has a quick ratio of 0.67, a current ratio of 0.67 and a debt-to-equity ratio of 0.58. The stock has a market cap of $247.40 million, a PE ratio of -1.22 and a beta of 1.04.

Institutional Investors Weigh In On P3 Health Partners

Several large investors have recently modified their holdings of PIII. BNP Paribas Arbitrage SNC acquired a new position in P3 Health Partners in the 3rd quarter valued at $44,000. Forum Financial Management LP acquired a new stake in P3 Health Partners in the first quarter valued at about $78,000. Goldman Sachs Group Inc. acquired a new position in P3 Health Partners during the 1st quarter worth approximately $80,000. State Board of Administration of Florida Retirement System acquired a new position in P3 Health Partners during the 2nd quarter worth approximately $34,000. Finally, Walleye Trading LLC purchased a new position in shares of P3 Health Partners during the 2nd quarter worth approximately $34,000. Hedge funds and other institutional investors own 7.75% of the company’s stock.

About P3 Health Partners

(Get Free Report)

P3 Health Partners Inc, a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. The company is based in Henderson, Nevada.

See Also

Earnings History and Estimates for P3 Health Partners (NASDAQ:PIII)

Before you consider P3 Health Partners, you’ll want to hear this.

MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and P3 Health Partners wasn’t on the list.

While P3 Health Partners currently has a “Moderate Buy” rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Wondering when you’ll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report


Source link

Check Also

Allworth Financial LP Raises Stock Position in Alexandria Real Estate Equities, Inc. (NYSE:ARE)

Allworth Financial LP increased its stake in Alexandria Real Estate Equities, Inc. (NYSE:ARE – Free …

Leave a Reply

Your email address will not be published. Required fields are marked *